Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

NCT: NCT06282809 · RECRUITING

NCT IDNCT06282809
StatusRECRUITING
Start Date2024-12-10
Completion2028-08
SponsorHistoSonics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this trial is to evaluate the safety of the HistoSonics Edison System for the destruction of pancreatic adenocarcinomas using histotripsy.

Frequently Asked Questions

What is The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy?

The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy is a clinical trial registered under NCT06282809. Current status: RECRUITING.

What is the status of NCT06282809?

The current status of NCT06282809 (The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy) is: RECRUITING.

When did The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy start?

The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy started on 2024-12-10.

Related Devices

K233466Edison SystemHistoSonics, Inc. K241902Edison SystemHistoSonics, Inc. K252947HistoSonics® Planning ToolHistoSonics, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑